Health Policy & Advocacy
Resources
Basic InformationMore InformationLatest News
Could Profit Be a Factor in Kidney Transplant Decisions?Get Up-to-the-Minute Safety Alerts Sent Straight to Your InboxPurdue Pharma to Settle Opioid Crisis Lawsuits, May Pay Up to $12 BillionWould a Health Warning on Every Cigarette Help Smokers Quit?Docs Prescribe More Opioids at Certain Time of DayFDA Warns Juul About Illegal Marketing Claims and Pitch to YouthComing Soon: A 'Pot Breathalyzer'?More CT, MRI Scans Being Used, Despite Calls to Cut BackCancer Overtakes Heart Disease as #1 Killer of Middle-Aged in Wealthy NationsOxyContin Maker Purdue Offering Up to $12 Billion to Settle Opioid ClaimsThousands of Kidneys Thrown Away by U.S. Transplant CentersJudge Orders Johnson & Johnson to Pay $572 Million Over Opioid Drug CrisisEvery Sudden Infant Death Deserves a Closer Look: ReportYour Chocolate Pot 'Edible' Could Hold a Hidden DangerCBD Is the Rage, But More Science Needed on Safety, EffectivenessMany Parents Would Switch Doctors Over Vaccination Policy, Poll FindsPot Poisonings Among Kids, Teens Double After Medical Marijuana Law PassedNearly Half of U.S. Patients Keep Vital Secrets From Their DoctorsFDA Proposes Graphic Warning Labels on CigarettesMany Doctors Refusing Care of People Prescribed OpioidsAll U.S. Adults Should Be Screened for Illicit Drug Use, National Panel UrgesAmericans' Trust in Scientists Follows a Sharp Political DivideRaising Legal Smoking Age to 21 WorksPure CBD Won't Make You Fail a Drug Test, But…Health Tip: Donate Blood SafelyRoutine Screening for Pancreatic Cancer Not Warranted, Expert Panel SaysResearchers 'Spin' Clinical Trial Findings in Top Psych Journals: StudyMore 'Buyer Beware' Warnings for Unregulated Stem Cell ClinicsSome of Most Common, Deadly Cancers Get the Least Research MoneyTraveling Abroad? Make Sure Your Measles Shot Is Up to DateHey! That's the Wrong Knee, DoctorBlood Donations Needed: Red CrossKeep Unused Meds Out of the Hands of AddictsFew U.S. Universities Are Smoke-FreeNeed Emergency Air Lift to Hospital? It Could Cost You $40,000California Took on Anti-Vaxxers, and WonAnti-Vaccine Movement a 'Man-Made' Health Crisis, Scientists WarnAHA News: Even the Threat of Homelessness May Bring Higher Stroke RiskFDA Warns Two Kratom Marketers About False ClaimsExperts Want Doctors to Add Vaping to Youth Prevention PitchMany Health Care Workers With Flu, Colds Still Go to Work: StudyGlobal Efforts to Cut Smoking Show Mixed ResultsOne Simple Food Substitution Might Help Save the PlanetAHA News: 3 Simple Steps Could Save 94 Million Lives WorldwideRace Affects Life Expectancy in Major U.S. CitiesDrugstores Often Don't Have Opioid Antidote in Stock, Philly Study ShowsAntibiotics Pollute Rivers Worldwide: StudyAHA News: For LGBTQ Patients, Discrimination Can Become Barrier to Medical CareImmigrants Make Up 1 in 4 U.S. Health Care WorkersFDA Takes Hard Look at CBD
Questions and AnswersVideosLinksBook Reviews
Related Topics

Health Insurance
Healthcare

OxyContin Maker Purdue Offering Up to $12 Billion to Settle Opioid Claims

HealthDay News
by -- E.J. Mundell
Updated: Aug 27th 2019

new article illustration

TUESDAY, Aug. 27, 2019 (HealthDay News) -- Purdue Pharma, the drug giant many have blamed for the ongoing U.S. opioid abuse crisis, has offered $10 billion to $12 billion to settle more than 2,000 lawsuits lodged against it, NBC News is reporting.

The news comes a day after the first of many pending state-driven opioid lawsuits -- this one lodged by Oklahoma -- ended in a judge ruling that the Johnson & Johnson company must pay out $572 million over damage caused to the state from opioid sales.

On Tuesday, NBC News reported that Purdue Pharma, owned by the wealthy Sackler family, is offering plaintiffs in over 2,000 cases up to $12 billion to settle those claims.

Two unnamed people familiar with negotiations that took place in Cleveland on Aug. 20 said the potential deal has been discussed by lawyers representing Purdue and at least 10 state attorneys general. David Sackler represented the family at the meetings, NBC News said.

Many of the thousands of lawsuits have been grouped into larger, combined suits. Most claim that Purdue and the Sacklers used deceptive marketing practices to downplay the potential harms from opioid painkillers such as OxyContin, a Purdue product. The result, states say, is more than 400,000 American opioid-related deaths occurring between 1999 and 2017.

"The Sackler family built a multibillion-dollar drug empire based on addiction," New Jersey state Attorney General Gurbir Gerwal said in May as his state announced their lawsuit.

But Purdue and the Sackler family have consistently denied those accusations, and they framed the proposed settlement as simply a quicker way to help those impacted by the opioid crisis.

"While Purdue Pharma is prepared to defend itself vigorously in the opioid litigation, the company has made clear that it sees little good coming from years of wasteful litigation and appeals," the company said in a statement released to NBC News. "The people and communities affected by the opioid crisis need help now. Purdue believes a constructive global resolution is the best path forward, and the company is actively working with the state attorneys general and other plaintiffs to achieve this outcome."

The new settlement would include a plan for Purdue to declare Chapter 11 bankruptcy and then re-form as a for-profit "public benefit trust," according to the purported deal, NBC News said.

Included in the deal would be $4 billion in drugs, including medicines used to help people fight overdose and addiction. In addition, all future profits from OxyContin and a soon-to-be-approved overdose rescue drug, Nalmefene, would go to the cities and states should they approve the deal, NBC News said.

The new trust would be overseen by independent, court-appointed "well-recognized experts" as trustees, who would in turn appoint a board of directors. The trust would exist for at least 10 years.

The Sacklers would give up ownership of Purdue, two people familiar with the deal told NBC News. The Sacklers themselves as a family would put another $3 billion into the settlement fund.

According to Forbes magazine, the Sacklers are the 19th richest family in the United States, with a combined wealth of $13 billion shared among 20 family members. Purdue earned more than $35 billion from sales of OxyContin alone, NBC News said.

If the assembled plaintiffs in the case decide not to take the deal offered by Purdue, the company will go ahead and declare bankruptcy anyway, NBC's sources said. But a liquidated Purdue may have much less money to offer plaintiffs.

More information

The U.S. National Institute on Drug Abuse has more about prescription opioids.




Facebook

Amazon Smile

To quit smoking, call Connecticut QuitLine at 1-800-QUIT-NOW.

Children and Adult services are available now with no wait time.  Please contact HBH Intake Department at 860-548-0101, option 2.

 


powered by centersite dot net